Avanza Fonder AB Purchases Shares of 36,433 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avanza Fonder AB acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 36,433 shares of the medical equipment provider's stock, valued at approximately $19,017,000. Intuitive Surgical makes up about 0.6% of Avanza Fonder AB's portfolio, making the stock its 26th biggest position.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. State Street Corp lifted its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC increased its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Geode Capital Management LLC raised its stake in Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock valued at $3,677,194,000 after buying an additional 143,440 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock worth $2,349,441,000 after acquiring an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. grew its stake in shares of Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock worth $1,890,676,000 after acquiring an additional 24,183 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $8.56 on Friday, hitting $592.64. 2,630,118 shares of the company's stock were exchanged, compared to its average volume of 1,158,623. The stock has a market capitalization of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68. The company has a 50-day simple moving average of $540.66 and a 200-day simple moving average of $498.77.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the firm's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the company's stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares of the company's stock, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 in the last ninety days. Corporate insiders own 0.80% of the company's stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on ISRG shares. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James raised their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research report on Monday, October 14th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.